SMO ClinPlus Co. Ltd. (301257) — Capital Reinvestment Ratio
SMO ClinPlus Co. Ltd. (301257) has a Capital Reinvestment Ratio of 0.22x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥35.69 Million) in capital expenditures (CN¥7.83 Million). See SMO ClinPlus Co. Ltd. (301257) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SMO ClinPlus Co. Ltd. Capital Reinvestment Ratio (2019–2025)
This chart tracks SMO ClinPlus Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods. Check cash flow reinvestment rate of SMO ClinPlus Co. Ltd. to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for SMO ClinPlus Co. Ltd. (2019–2025)
Year-by-year Capital Reinvestment Ratio for SMO ClinPlus Co. Ltd. from 2019 to 2025. For live market cap and broader valuation context, see SMO ClinPlus Co. Ltd. (301257) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥35.69 Million | CN¥7.83 Million | ▲ +146.0% |
| 2023 | 0.09x | CN¥114.85 Million | CN¥10.25 Million | ▼ -54.6% |
| 2022 | 0.20x | CN¥40.44 Million | CN¥7.95 Million | ▲ +85.4% |
| 2021 | 0.11x | CN¥41.52 Million | CN¥4.40 Million | ▼ -41.7% |
| 2020 | 0.18x | CN¥22.45 Million | CN¥4.08 Million | ▲ +68.6% |
| 2019 | 0.11x | CN¥45.53 Million | CN¥4.91 Million | — |